UNSPSC 51303002: Voriconazole

This classification denotes an antifungal agent with the molecular formula C16H14F3N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JFU09I87TR, chemically known as 4-pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1h-1,2,4-triazol-1-ylmethyl)-, (r-(r*,s*))- but generally known as voriconazole, which bears US NIH Compound Identifier 71616. European Medicines Agency schedules Voriconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00087MIG.

UNSPSC 51303002 Voriconazole is a Commodity code nominally designating an antifungal pharmaceutical product, but the most recent state and local opportunities posted under this code show no procurement activity aligned with the code's stated scope. The City of Austin solicited liquid aluminum sulfate (alum) for wastewater treatment under IFB 2200 CSH1061, and the City of Tampa solicited medical aid supplies including bandages, antiseptic sprays, and first aid kits under ITB 25-P-00157. Neither opportunity involves voriconazole or pharmaceutical procurement. The code shows a clear mismatch between its nominal pharmaceutical designation and the chemical treatment and first aid supply work actually tagged to it in recent state and local notices.

Given this misalignment, the code presents limited decision relevance for vendors focused on pharmaceutical supply or antifungal drug distribution to state and local health agencies. Business development professionals should verify coding accuracy with issuing bodies before pursuing opportunities tagged to this code, as the recent notices suggest either systematic miscoding or incidental placement of non-pharmaceutical work under a pharmaceutical commodity classification. No voriconazole-specific opportunities appear in the recent state and local contract activity block.